JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

lunes, 23 de marzo de 2026, 8:47 am ET1 min de lectura
MREO--

JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios